Medicine and Dentistry

1. Acute B-Cell Lymphoblastic Leukemia 85%
2. Acute Lymphoblastic Leukemia 42%
3. Acute Myeloid Leukemia 14%
4. Adult 42%
5. Adverse Event 25%
6. Age 17%
7. Allogeneic Hematopoietic Stem Cell Transplantation 14%
8. Allogeneic Stem Cell Transplantation 17%
9. Aplasia 27%
10. B Cell 70%
11. B Cell Development 14%
12. Bone Marrow 30%
13. Cells 71%
14. Chimeric Antigen Receptor 42%
15. Chimeric Antigen Receptor T-Cell 51%
16. Chimeric Antigen Receptor T-Cell Immunotherapy 10%
17. Clinical Trial 14%
18. Cord Blood 14%
19. Cytokine Release Syndrome 19%
20. Differentiation 28%
21. down Regulation 10%
22. Engraftment 8%
23. Event Free Survival 38%
24. Follow up 8%
25. Graft Versus Leukemia Effect 42%
26. Granulocyte Macrophage Colony Stimulating Factor 42%
27. Hematopoietic Stem Cell Transplantation 14%
28. Human Leukocyte Antigen 14%
29. Hypogammaglobulinemia 8%
30. Identity 14%
31. Incidence 19%
32. Lentivirus Vector 14%
33. Leukemia Antigen 14%
34. Maturation 14%
35. Minimal Residual Disease 25%
36. Morphology 10%
37. Patient 100%
38. Pediatrics 42%
39. Prognosis 8%
40. Spontaneous Remission 38%
41. Survival Rate 10%
42. Synapsin I 28%
43. T Cell 53%
44. T Cell Development 14%
45. Therapeutic Procedure 64%
46. Therapeutics 8%
47. Toxicity 85%
48. Tumor Protein 28%
49. Wilms' Tumor 28%
50. Young Adult 42%